Related Experiment Video
Updated: Nov 3, 2025

05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
6.3K
Amyloids: The History of Toxicity and Functionality
Elmira I Yakupova1,2, Liya G Bobyleva1, Sergey A Shumeyko1
1Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, 142290 Moscow, Russia.
Biology
|June 2, 2021
Summary
Amyloid aggregates, like those implicated in Alzheimer's disease (AD), are protein structures resistant to degradation. This review examines amyloid toxicity, anti-amyloid therapy challenges, and potential beneficial roles of amyloids.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Proteins require specific molecular structures for function.
- Misfolding and aggregation can lead to amyloid formation, characterized by a cross-β structure.
- Amyloids resist proteolysis, accumulating in tissues and causing diseases like Alzheimer's disease (AD).
Purpose of the Study:
- To review the history of amyloid-beta (Aβ) toxicity, the primary cause of AD.
- To highlight challenges in current anti-amyloid therapies.
- To explore emerging perspectives on the positive roles of amyloids in various organisms.
Main Methods:
- Literature review focusing on amyloid structure and function.
- Historical analysis of Aβ toxicity research.
- Examination of therapeutic strategies and recent findings on amyloid functions.
Main Results:
- Aβ-amyloid accumulation is the leading hypothesis for AD pathogenesis.
- Significant challenges exist in developing effective anti-amyloid therapies.
- New research suggests amyloids may have beneficial roles in biological systems.
Conclusions:
- Understanding amyloid structure and aggregation is crucial for disease intervention.
- Overcoming therapeutic hurdles is essential for treating amyloidosis.
- Further research is needed to elucidate the dual nature of amyloids.
Related Concept Videos
Amyloid Fibrils
10.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.9K
Amyloid Fibrils
6.0K
6.0K
Alzheimer's Disease: Overview
948
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
948

